BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27709434)

  • 1. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
    Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
    Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.
    López-Cortés LE; Del Toro MD; Gálvez-Acebal J; Bereciartua-Bastarrica E; Fariñas MC; Sanz-Franco M; Natera C; Corzo JE; Lomas JM; Pasquau J; Del Arco A; Martínez MP; Romero A; Muniain MA; de Cueto M; Pascual A; Rodríguez-Baño J;
    Clin Infect Dis; 2013 Nov; 57(9):1225-33. PubMed ID: 23929889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist.
    Hadano Y; Kakuma T; Matsumoto T; Ishibashi K; Isoda M; Yasunaga H
    Int J Infect Dis; 2021 Feb; 103():308-315. PubMed ID: 33278619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
    Fätkenheuer G; Preuss M; Salzberger B; Schmeisser N; Cornely OA; Wisplinghoff H; Seifert H
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):157-62. PubMed ID: 14986158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
    Rosa R; Wawrzyniak A; Sfeir M; Smith L; Abbo LM
    J Hosp Med; 2016 Jan; 11(1):27-32. PubMed ID: 26381394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
    Smith JR; Frens JJ; Snider CB; Claeys KC
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
    Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
    Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
    Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
    Martin L; Harris MT; Brooks A; Main C; Mertz D
    BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study.
    Schwalb A; Cachay R; de la Flor A; García C; Seas C
    Int J Infect Dis; 2020 Jul; 96():601-606. PubMed ID: 32505877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of infectious diseases consultation for children with Staphylococcus aureus bacteremia.
    Whittington KJ; Ma Y; Butler AM; Hogan PG; Ahmed F; Flowers J; Milburn G; Morelli JJ; Newland JG; Fritz SA
    Pediatr Res; 2022 Dec; 92(6):1598-1605. PubMed ID: 35982140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
    Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
    Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease.
    Kang CK; Kwak YG; Park Y; Song KH; Kim ES; Jung SI; Park KH; Park WB; Kim NJ; Kim YK; Jang HC; Lee S; Jeon JH; Kwon KT; Kim CJ; Kim YS; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1119-1123. PubMed ID: 29667110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
    Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
    Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome.
    Asgeirsson H; Gudlaugsson O; Kristinsson KG; Vilbergsson GR; Heiddal S; Haraldsson A; Weiland O; Kristjansson M
    Pediatr Infect Dis J; 2015 Feb; 34(2):140-4. PubMed ID: 24992124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers.
    Imaizumi T; Hasegawa T; Nomura A; Sasaki S; Nishiwaki H; Ozeki T; Shimizu H; Minatoguchi S; Yamakawa T; Yazawa M; Uchida D; Kawarazaki H; Miyamoto M; Suzuki T; Koitabashi K; Furusho M; Fujita Y
    Ther Apher Dial; 2017 Aug; 21(4):354-360. PubMed ID: 28498647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.